Loading stock data…
RadNet (RDNT)
$59.28-1.46 (-2.40%)
After Hours$59.70+0.42 (+0.71%)· Last close Jun 29
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
RadNet, Inc. in the Healthcare sector is trading at $59.28 with a market capitalization of $4.6B. Wall Street consensus targets $89.75 (8 analysts), implying a +51.4% move over the next 12 months. The stock is currently 31% below its 52-week high of $85.84, remaining 12.7% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +51.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $575.63M↑ | $547.71M↑ | $522.87M↑ | $498.23M↑ | $471.40M |
| Gross Profit | $25.12M↓ | $75.93M↑ | $72.49M↑ | $69.14M↑ | $17.92M |
| Operating Income | -$19.85M↓ | $35.08M↑ | $32.69M↓ | $33.15M↑ | -$17.56M |
| Net Income | -$33.47M↓ | -$597,000↓ | $5.42M↓ | $14.45M↑ | -$37.93M |
Peer Comparison
JNJUNHPFE
Fundamentals
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.56B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.31%
Volume
Today's trading volume
801,195
Recent News
3 Small-Cap Stocks with Questionable Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Why RadNet (RDNT) Stock Is Down Today
Shares of diagnostic imaging company RadNet (NASDAQ:RDNT) fell 3.9% in the afternoon session after one of its key executives sold over $2.5 million worth of company stock.
RadNet’s AI Reporting Pro And New Loan Put Focus On Valuation
RadNet (NasdaqGM:RDNT) has launched Reporting Pro, an AI-powered radiology reporting solution offered both across its own network and to external customers. The company has also secured a $250 million incremental term loan with improved financing terms to support acquisitions, expansion, and partnerships. RadNet enters this phase with its share price at $56.71 and a mixed return profile. The stock is up 4.4% over the past week and 7.0% over the past month, while year to date it is down...
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 6.4%, nearly mirroring the S&P 500.
RadNet (RDNT): Buy, Sell, or Hold Post Q1 Earnings?
RadNet has gotten torched over the last six months - since December 2025, its stock price has dropped 30.5% to $52.97 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.